Enhancing business success and organizational trajectory, I oversee all financial aspects, including strategic investments, P&L, cash flow, and corporate communication. I collaborate with partners, clients, consultants, and academic and governing entities. Furthermore, I maintain and foster high-value relationships with key thought leaders in the engineering industry to obtain endorsements and enhance technology visibility, reporting to the CEO.Primary focus:➜ Generating 100%… Show more Enhancing business success and organizational trajectory, I oversee all financial aspects, including strategic investments, P&L, cash flow, and corporate communication. I collaborate with partners, clients, consultants, and academic and governing entities. Furthermore, I maintain and foster high-value relationships with key thought leaders in the engineering industry to obtain endorsements and enhance technology visibility, reporting to the CEO.Primary focus:➜ Generating 100% funding with multi-million-dollar projected revenues.➜ Securing and continuing to prospect multiple five-to-six-figure electronic, software and mechanical engineering contracts for clients located throughout the world.➜Formulating DUO’s outsourcing strategy to build and enhance relationships with U.S., European, and Asian engineering firms.➜ Collaborating with key thought leaders that are assisting DUO in expanding its technological footprint and driving profitable growth.➜ Enhancing DUO’s intellectual property portfolio, which includes patents that protect the Company’s flagship LTTC technology in the U.S. and +12 European countries. Show less

I co-founded an entirely new class of clinical and industrial diagnostics that has achieved the lowest limit of detection across the laboratory testing spectrum.Managing a team of up to 16 scientists and seven consultants across multiple geographies, I spearheaded the advancements of scientific initiatives, managed all day-to-day operations and budgeting, modified strategic focus and objectives to meet ever-expanding goals, assessed competing technologies in target markets, and built… Show more I co-founded an entirely new class of clinical and industrial diagnostics that has achieved the lowest limit of detection across the laboratory testing spectrum.Managing a team of up to 16 scientists and seven consultants across multiple geographies, I spearheaded the advancements of scientific initiatives, managed all day-to-day operations and budgeting, modified strategic focus and objectives to meet ever-expanding goals, assessed competing technologies in target markets, and built relationships with key leaders in various diagnostic markets, and reported to the CEO.Notable achievements include:➜ Assisted in the multi-billion-dollar acquisition of Covance.➜ Secured millions in funding, secured more than 30 patents, and achieved four independentcertifications to validate an entirely new class of diagnostics for commercial use.➜ Built two laboratories from the ground up by securing funding from management, sourcing the appropriate expertise, acquiring all instrumentation and supplies, and beginning operations on time and under budget.➜ Generated approximately +25% new institutional ownership during my tenor in managing Corporate Communications and Investor Relations, increasing the Company’s market cap by crafting and relaying a focused strategy with the CEO. Show less

I covered the healthcare services industry, focusing on clinical labs, skilled nursing, home health, dialysis, and oxygen companies.I created financial models and drafted hundreds of publications for distribution across the investment community.I presented investment theses on differentiating coverages to buy-side clients and Wachovia’s Sales and Trading Division. In addition, I was among the first analysts to publish on the significance of personalized medicine and companion… Show more I covered the healthcare services industry, focusing on clinical labs, skilled nursing, home health, dialysis, and oxygen companies.I created financial models and drafted hundreds of publications for distribution across the investment community.I presented investment theses on differentiating coverages to buy-side clients and Wachovia’s Sales and Trading Division. In addition, I was among the first analysts to publish on the significance of personalized medicine and companion diagnostics, and later created and developed personalized antibiotic susceptibility diagnostics at Labcorp. Show less

I was responsible for managing corporate communications and special projects for the CEO as well as the Purchasing Division, generating savings by introducing enhanced instrumentation in the Company’s labs.I reviewed and implemented new technologies and optimal purchasing strategies to drive further savings, assessed a wide range of growth opportunities, and managed investor communication to enhance institutional visibility and ownership.Among my achievements were increasing… Show more I was responsible for managing corporate communications and special projects for the CEO as well as the Purchasing Division, generating savings by introducing enhanced instrumentation in the Company’s labs.I reviewed and implemented new technologies and optimal purchasing strategies to drive further savings, assessed a wide range of growth opportunities, and managed investor communication to enhance institutional visibility and ownership.Among my achievements were increasing institutional ownership by +50%, enhancing components of lab efficiency by 15%, and proportionally lowering operational and personnel costs.Lastly, I skillfully promoted pain management testing, an increasingly prevalent and profitable business within human health and clinical diagnostics. Show less